Lansdale, PA, United States of America

Gregory C Leo


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Dear valued reader,

Title: Innovator Spotlight: Gregory C Leo

Introduction: Gregory C Leo, a talented inventor based in Lansdale, PA (US), has made groundbreaking contributions in the field of glucose absorption and excretion indicators through his patented methods using alpha-methylglucoside (AMG).

Latest Patents: Gregory C Leo holds a significant patent titled "Methods of using alpha-methylglucoside (AMG) as an indicator for glucose absorption and excretion." These innovative methods utilize AMG in vivo to assess glucose absorption from the gastrointestinal system or glucose excretion in the urine, enabling various applications in research and diagnostics.

Career Highlights: Gregory C Leo is associated with Janssen Pharmaceutica Nv, a leading pharmaceutical company known for its cutting-edge research and development initiatives. His collaboration with the company underscores his dedication to advancing medical science through inventive solutions.

Collaborations: Throughout his career, Gregory C Leo has worked closely with esteemed colleagues such as Keith T Demarest and James M Lenhard. Together, they have contributed to the collective knowledge in the field of pharmaceuticals and biochemistry, enriching the scientific community with their expertise.

Conclusion: Gregory C Leo's innovative methods using AMG as a glucose indicator showcase his commitment to driving advancements in healthcare and diagnostics. His contributions will continue to inspire advancements in the field, shaping the future of medical research.

Warm regards,

Diya at iDIYas

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…